vs
Side-by-side financial comparison of Aquestive Therapeutics, Inc. (AQST) and INTERGROUP CORP (INTG). Click either name above to swap in a different company.
INTERGROUP CORP is the larger business by last-quarter revenue ($17.3M vs $13.0M, roughly 1.3× Aquestive Therapeutics, Inc.). INTERGROUP CORP runs the higher net margin — 8.8% vs -244.8%, a 253.6% gap on every dollar of revenue. On growth, INTERGROUP CORP posted the faster year-over-year revenue change (19.8% vs 9.7%). INTERGROUP CORP produced more free cash flow last quarter ($-481.0K vs $-8.6M). Over the past eight quarters, INTERGROUP CORP's revenue compounded faster (7.8% CAGR vs 3.9%).
Aquestive Therapeutics is a specialty pharmaceutical company focused on developing and commercializing innovative treatments for central nervous system disorders. It leverages proprietary drug delivery technologies to create accessible, patient-friendly therapeutic options, serving healthcare providers and patients across North America and European markets, with core offerings addressing unmet needs in neurology and psychiatry.
Intergroup Corp is a diversified holding firm operating two core segments: real estate and hotel operations. It owns, manages and leases commercial and residential properties across the U.S., and runs limited-service hotels for leisure and business travelers.
AQST vs INTG — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $13.0M | $17.3M |
| Net Profit | $-31.9M | $1.5M |
| Gross Margin | 55.2% | — |
| Operating Margin | -221.6% | 11.6% |
| Net Margin | -244.8% | 8.8% |
| Revenue YoY | 9.7% | 19.8% |
| Net Profit YoY | -86.8% | 155.6% |
| EPS (diluted) | $-0.26 | $0.71 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.0M | $17.3M | ||
| Q3 25 | $12.8M | $17.9M | ||
| Q2 25 | $10.0M | $16.2M | ||
| Q1 25 | $8.7M | $16.8M | ||
| Q4 24 | $11.9M | $14.4M | ||
| Q3 24 | $13.5M | $16.9M | ||
| Q2 24 | $20.1M | $13.4M | ||
| Q1 24 | $12.1M | $14.9M |
| Q4 25 | $-31.9M | $1.5M | ||
| Q3 25 | $-15.4M | $-535.0K | ||
| Q2 25 | $-13.5M | $-2.2M | ||
| Q1 25 | $-22.9M | $-578.0K | ||
| Q4 24 | $-17.1M | $-2.7M | ||
| Q3 24 | $-11.5M | $-398.0K | ||
| Q2 24 | $-2.7M | $-4.9M | ||
| Q1 24 | $-12.8M | $-3.2M |
| Q4 25 | 55.2% | — | ||
| Q3 25 | 64.8% | — | ||
| Q2 25 | 54.4% | — | ||
| Q1 25 | 58.1% | — | ||
| Q4 24 | 61.9% | — | ||
| Q3 24 | 67.2% | — | ||
| Q2 24 | 77.5% | — | ||
| Q1 24 | 63.6% | — |
| Q4 25 | -221.6% | 11.6% | ||
| Q3 25 | -89.6% | 15.3% | ||
| Q2 25 | -113.6% | 8.1% | ||
| Q1 25 | -222.1% | 14.0% | ||
| Q4 24 | -114.4% | 5.9% | ||
| Q3 24 | -61.2% | 18.5% | ||
| Q2 24 | 0.3% | 3.7% | ||
| Q1 24 | -74.3% | 4.8% |
| Q4 25 | -244.8% | 8.8% | ||
| Q3 25 | -120.6% | -3.0% | ||
| Q2 25 | -135.4% | -13.9% | ||
| Q1 25 | -263.0% | -3.4% | ||
| Q4 24 | -143.7% | -18.9% | ||
| Q3 24 | -85.0% | -2.4% | ||
| Q2 24 | -13.7% | -36.7% | ||
| Q1 24 | -106.4% | -21.3% |
| Q4 25 | $-0.26 | $0.71 | ||
| Q3 25 | $-0.14 | $-0.25 | ||
| Q2 25 | $-0.14 | — | ||
| Q1 25 | $-0.24 | $-0.27 | ||
| Q4 24 | $-0.18 | $-1.26 | ||
| Q3 24 | $-0.13 | $-0.18 | ||
| Q2 24 | $-0.03 | — | ||
| Q1 24 | $-0.17 | $-1.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $7.5M |
| Total DebtLower is stronger | $27.5M | $233.2M |
| Stockholders' EquityBook value | $-33.7M | $-85.2M |
| Total Assets | $160.4M | $101.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $7.5M | ||
| Q3 25 | $129.1M | $6.0M | ||
| Q2 25 | $60.5M | $6.1M | ||
| Q1 25 | $68.7M | $4.8M | ||
| Q4 24 | $71.5M | $15.4M | ||
| Q3 24 | $77.9M | $12.2M | ||
| Q2 24 | $89.9M | $11.6M | ||
| Q1 24 | $95.2M | $19.5M |
| Q4 25 | $27.5M | $233.2M | ||
| Q3 25 | $45.0M | $237.8M | ||
| Q2 25 | $45.0M | $240.5M | ||
| Q1 25 | $45.0M | $241.5M | ||
| Q4 24 | $32.5M | $227.2M | ||
| Q3 24 | $45.0M | $218.1M | ||
| Q2 24 | $45.0M | $225.7M | ||
| Q1 24 | $45.0M | $225.0M |
| Q4 25 | $-33.7M | $-85.2M | ||
| Q3 25 | $-4.1M | $-86.7M | ||
| Q2 25 | $-72.6M | $-86.1M | ||
| Q1 25 | $-60.9M | $-84.5M | ||
| Q4 24 | $-60.2M | $-83.9M | ||
| Q3 24 | $-45.4M | $-80.9M | ||
| Q2 24 | $-35.5M | $-80.3M | ||
| Q1 24 | $-36.3M | $-76.4M |
| Q4 25 | $160.4M | $101.1M | ||
| Q3 25 | $163.6M | $102.5M | ||
| Q2 25 | $93.7M | $104.1M | ||
| Q1 25 | $102.2M | $103.2M | ||
| Q4 24 | $101.4M | $110.6M | ||
| Q3 24 | $110.0M | $109.3M | ||
| Q2 24 | $117.6M | $107.8M | ||
| Q1 24 | $129.5M | $119.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.5M | $-23.0K |
| Free Cash FlowOCF − Capex | $-8.6M | $-481.0K |
| FCF MarginFCF / Revenue | -65.7% | -2.8% |
| Capex IntensityCapex / Revenue | 0.7% | 2.6% |
| Cash ConversionOCF / Net Profit | — | -0.02× |
| TTM Free Cash FlowTrailing 4 quarters | $-53.0M | $739.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-8.5M | $-23.0K | ||
| Q3 25 | $-12.6M | $-296.0K | ||
| Q2 25 | $-7.9M | $5.9M | ||
| Q1 25 | $-23.4M | $-854.0K | ||
| Q4 24 | $-6.5M | $-781.0K | ||
| Q3 24 | $-11.9M | $3.4M | ||
| Q2 24 | $-7.0M | $6.8M | ||
| Q1 24 | $-10.4M | $1.9M |
| Q4 25 | $-8.6M | $-481.0K | ||
| Q3 25 | $-12.9M | $-1.3M | ||
| Q2 25 | $-8.0M | $3.6M | ||
| Q1 25 | $-23.5M | $-1.2M | ||
| Q4 24 | $-6.5M | $-1.1M | ||
| Q3 24 | $-12.0M | $3.1M | ||
| Q2 24 | $-7.0M | $2.7M | ||
| Q1 24 | $-10.4M | $1.1M |
| Q4 25 | -65.7% | -2.8% | ||
| Q3 25 | -100.6% | -7.1% | ||
| Q2 25 | -80.2% | 22.5% | ||
| Q1 25 | -269.9% | -6.8% | ||
| Q4 24 | -54.8% | -7.8% | ||
| Q3 24 | -88.3% | 18.3% | ||
| Q2 24 | -35.0% | 20.4% | ||
| Q1 24 | -86.4% | 7.6% |
| Q4 25 | 0.7% | 2.6% | ||
| Q3 25 | 1.8% | 5.4% | ||
| Q2 25 | 1.1% | 13.9% | ||
| Q1 25 | 1.5% | 1.8% | ||
| Q4 24 | 0.1% | 2.4% | ||
| Q3 24 | 0.6% | 1.6% | ||
| Q2 24 | 0.2% | 30.4% | ||
| Q1 24 | 0.2% | 4.9% |
| Q4 25 | — | -0.02× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AQST
Segment breakdown not available.
INTG
| Hotel Operations | $12.7M | 73% |
| Real Estate Operation | $4.6M | 27% |
